skip to content

Cambridge Public Health

 

My research centres around two research topics: one, the role of IP in genomic medicine; and two, IP and access policies at biobanks.

Publications from Elements

Journal articles

2022 (Accepted for publication)

  • Riobo Aboy, P., Liddell, K., Jordan, M., Liddicoat, J. and Crespo, C., 2022 (Accepted for publication). European Patent Protection for Medical Uses of Known Products and Drug Repurposing Nature Biotechnology,
    Doi: 10.1038/s41587-022-01269-3
  • 2021 (Accepted for publication)

  • Liddicoat, J., Liddell, K. and Fritz, Z., 2021 (Accepted for publication). Reconsidering Repositioning Incentives: An Empirical Legal Analysis of Market Protection for New Therapeutic Indications European Pharmaceutical Law Review,
  • Liddicoat, J. and Wested, J., 2021 (Accepted for publication). Repositioning for rare diseases – too much, too little or just right? Nordic Intellectual Property Law Review,
  • Liddicoat, J., Liddell, K., Aboy, M. and Wested, J., 2021 (Accepted for publication). Has the EU incentive for drug repositioning been effective? An empirical analysis of the “+1” regulatory exclusivity IIC International Review of Intellectual Property and Competition Law,
  • Jordan, M., Liddicoat, J. and Liddell, K., 2021 (Accepted for publication). An Empirical Study of Large, Human Biobanks: Intellectual Property Policies and Financial Conditions for Access Journal of Law and the Biosciences,
  • Liddicoat, J. and Parish, J., 2021 (Accepted for publication). Ironing out the wrinkles: reforms to Crown use and compulsory licensing to help prepare the Patents Act 1977 for the next health crises Intellectual Property Quarterly,
  • Riobo Aboy, P., Liddell, K., Liddicoat, J., Crespo, C. and Jordan, M., 2021 (Accepted for publication). Mapping the European Patent Landscape for Medical Uses of Known Products Nature Biotechnology,
  • 2021

  • 2021. New EU Pharmaceutical Law and Policy European Pharmaceutical Law Review, v. 4
    Doi: 10.21552/eplr/2020/4/10
  • 2020 (Accepted for publication)

  • Aboy, M., Crespo, C., Liddell, K., Davey, N., Liddicoat, J. and Minssen, T., 2020 (Accepted for publication). One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections? Nature Biotechnology,
  • 2020

  • Liddicoat, J., Liddell, K., McCarthy, AH., Hogarth, S., Aboy, M., Nicol, D., Patton, S. and Hopkins, MM., 2020. Reply to C.D. Richter. European Journal of Human Genetics,
    Doi: http://doi.org/10.1038/s41431-020-0588-x
  • Liddicoat, J., Liddell, K., McCarthy, A., Hogarth, S., Aboy, M., Nicol, D., Patton, S. and Hopkins, MM., 2020. Reply to C.D. Richter European Journal of Human Genetics,
  • 2019 (Accepted for publication)

  • Liddicoat, J., Liddell, K., McCarthy, A., Hogarth, S., Nicol, D., Patton, S. and Hopkins, M., 2019 (Accepted for publication). Continental drift? Do European clinical genetic testing laboratories have a patent problem? European Journal of Human Genetics,
  • Liddicoat, J., Liddell, K. and Aboy, M., 2019 (Accepted for publication). The Effects of Myriad and Mayo on Molecular Test Development in the US and Europe: Interviews from the Frontline Vanderbilt Journal of Entertainment and Technology Law, v. 22
    Doi: http://doi.org/10.2139/ssrn.3381553
  • 2019

  • Aboy, M., Crespo, C., Liddell, K., Minssen, T. and Liddicoat, J., 2019. Mayo's impact on patent applications related to biotechnology, diagnostics and personalized medicine. Nat Biotechnol, v. 37
    Doi: http://doi.org/10.1038/s41587-019-0111-5
  • Liddicoat, J. and de Werra, J., 2019. When can exclusive licensees initiate patent infringement proceedings?—Lessons for global IP licensing transactions from two recent UK cases Journal of Intellectual Property Law & Practice, v. 14
    Doi: http://doi.org/10.1093/jiplp/jpy159
  • Nicol, D., Dreyfuss, RC., Gold, ER., Li, W., Liddicoat, J. and Van Overwalle, G., 2019. International Divergence in Gene Patenting. Annu Rev Genomics Hum Genet, v. 20
    Doi: http://doi.org/10.1146/annurev-genom-083118-015112
  • Aboy, M., Liddell, K., Crespo, C., Cohen, IG., Liddicoat, J., Gerke, S. and Minssen, T., 2019. How does emerging patent case law in the US and Europe affect precision medicine? Nat Biotechnol, v. 37
    Doi: http://doi.org/10.1038/s41587-019-0265-1
  • 2018 (Accepted for publication)

  • Powles, J. and Liddicoat, JE., 2018 (Accepted for publication). United Kingdom Patent Decisions 2017 IIC International Review of Intellectual Property and Competition Law,
  • 2018

  • Aboy, M., Crespo, C., Liddell, K., Liddicoat, J. and Jordan, M., 2018. Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts? Nat Biotechnol, v. 36
    Doi: http://doi.org/10.1038/nbt.4308
  • Liddicoat, JE., 2018. Divided Performance of Patented Methods in Australia: A Call to Codify Procured Infringement University of New South Wales Law Journal, v. 41
  • 2017

  • Liddicoat, J., 2017. Standing on the Edge – What Type of “Exclusive Licensees” Should be Able to Initiate Patent Infringement Actions? IIC - International Review of Intellectual Property and Competition Law, v. 48
    Doi: http://doi.org/10.1007/s40319-017-0620-z
  • Aboy, M., Liddicoat, J., Liddell, K., Jordan, M. and Crespo, C., 2017. After Myriad, what makes a gene patent claim 'markedly different' from nature? Nature Biotechnology, v. 35
    Doi: http://doi.org/10.1038/nbt.3953
  • Nicol, D., Eckstein, L., Morrison, M., Sherkow, JS., Otlowski, M., Whitton, T., Bubela, T., Burdon, KP., Chalmers, D., Chan, S., Charlesworth, J., Critchley, C., Crossley, M., de Lacey, S., Dickinson, JL., Hewitt, AW., Kamens, J., Kato, K., Kleiderman, E., Kodama, S., Liddicoat, J., Mackey, DA., Newson, AJ., Nielsen, J., Wagner, JK. and McWhirter, RE., 2017. Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic. Genome Medicine, v. 9
    Doi: http://doi.org/10.1186/s13073-017-0475-4
  • Nielsen, JL. and Liddicoat, JE., 2017. The Multiple Dimensions of Intellectual Property Infringement in the 3D Printing Era Australian Intellectual Property Journal,
  • 2016

  • Nicol, D., Bubela, T., Chalmers, D., Charbonneau, J., Critchley, C., Dickinson, J., Fleming, J., Hewitt, AW., Kaye, J., Liddicoat, J., McWhirter, R., Otlowski, M., Ries, NM., Skene, L., Stewart, C., Wagner, J. and Zeps, N., 2016. Precision medicine: Drowning in a regulatory soup? Journal of Law and the Biosciences, v. 3
    Doi: http://doi.org/10.1093/jlb/lsw018
  • Liddicoat, JE., Nielsen, JL. and Nicol, D., 2016. Three Dimensions of Patent Infringement: Liability for Creation and Distribution of CAD Files Australian Intellectual Property Journal,
  • Christie, AF., Dent, C. and Liddicoat, JE., 2016. The Examination Effect: A Comparison of the Outcome of Patent Examination in the US, Europe and Australia John Marshall Review of Intellectual Property Law, v. 16
  • Aboy, M., Liddell, K., Liddicoat, J. and Crespo, C., 2016. $\textit{Myriad's}$ impact on gene patents Nature Biotechnology, v. 34
    Doi: http://doi.org/10.1038/nbt.3719
  • 2015

  • Liddicoat, JE., 2015. Reluctance Realised? Emerging Problems with S 117(2)(b) of the Patents Act 1990 (Cth)
  • Liddicoat, J., Whitton, T. and Nicol, D., 2015. Are the gene-patent storm clouds dissipating? A global snapshot. Nat Biotechnol, v. 33
    Doi: http://doi.org/10.1038/nbt.3182
  • 2014

  • Liddicoat, JE., 2014. Re-Evaluating Innocent Infringement in Australia: Patent Numbers and Virtual Marking
  • Nicol, D., Hagger, M., Ries, N. and Liddicoat, J., 2014. Time to Get Serious about Privacy Policies: The Special Case of Genetic Privacy Federal Law Review, v. 42
    Doi: 10.22145/flr.42.1.7
  • Nielsen, JL., Nicol, D. and Liddicoat, JE., 2014. Sharing the Burden in Australian Drug Discovery and Development: Collaborative Trends in Translational Research
  • Liddicoat, JE. and Nicol, D., 2014. Re-Evaluating False Patent Marking in Australia
  • Nielsen, JL., Nicol, D., Liddicoat, JE. and Whitton, T., 2014. Another Missed Opportunity to Reform Compulsory Licensing and Crown Use in Australia Australian Intellectual Property Journal,
  • 2013 (Published online)

  • Nicol, D., Liddicoat, J. and Critchley, C., 2013 (Published online). A Role for Virtual Biotechnology Companies in Drug Discovery and Development? Journal of Commercial Biotechnology, v. 19
    Doi: 10.5912/jcb611
  • 2013

  • Nicol, D. and Liddicoat, J., 2013. Do patents impede the provision of genetic tests in Australia? Aust Health Rev, v. 37
    Doi: http://doi.org/10.1071/AH13029
  • 2012

  • Nicol, D. and Liddicoat, JE., 2012. Legislating to Exclude Gene Patents: Difficult and Unhelpful, or Useful and Feasible?
  • Book chapters

    2021 (Accepted for publication)

  • Sagar, A., Liddell, K., Liddicoat, J. and Aboy, M., 2021 (Accepted for publication). Patent Eligibility and Precision Medicine: Emerging Technologies, Legal Flux and Empirical Methods
    Doi: http://doi.org/10.4337/9781800884410.00007
  • 2019 (No publication date)

  • Liddicoat, JE. and Liddell, K., 2019 (No publication date). Open Innovation with Large Bioresources: Goals, Challenges and Proposals
    Doi: 10.2139/ssrn.2888871
  • 2019

  • Liddell, K., Liddicoat, J. and Jordan, M., 2019. IP policies for large bioresources: the fiction, fantasy, and future of openness
  • 2012

  • Christie, AF. and Liddicoat, JE., 2012. Balancing Copyright - A Survey of National Approaches, Chapter: Australia
  • Liddicoat, JE., 2012. Australia
  • Internet publications

    2020 (No publication date)

  • Liddicoat, J., Liddell, K. and Aboy, M., 2020 (No publication date). The Effects of Myriad and Mayo on Molecular Test Development in the US and Europe: Interviews from the Frontline
    Doi: 10.2139/ssrn.3381553
  • 2019

  • Aboy, M., Cohen, IG., Liddell, K., Liddicoat, J., Crespo, C., Gerke, S. and Minssen, T., 2019. How Does Emerging Patent Case Law in the US and Europe Affect Precision Medicine? How Will Today’s Patent Law Affect Tomorrow’s Innovation in the Areas of Biomarkers and Nature-Based Products; Diagnostics; and Algorithms, Big Data and AI?
  • 2018

  • Liddicoat, JE., 2018. Divided performance of patented methods in australia: A call to codify procured infringement
    Doi: http://doi.org/10.2139/ssrn.3043270
  • Other publications

    2019 (No publication date)

  • Liddicoat, JE., Skopek, JM. and Liddell, K., 2019 (No publication date). Precision Medicine: Legal and Ethical Challenges SSRN Electronic Journal,
    Doi: 10.2139/ssrn.3070388
  • Working papers

    2016

  • Liddell, K. and Liddicoat, J., 2016. Should We Change EU Law to Disallow DNA Patents?
  • Books

    2014 (No publication date)

  • Nicol, D., Nielsen, JL., Liddicoat, JE., Critchley, C. and Whitton, T., 2014 (No publication date). The Innovation Pool in Biotechnology: The Role of Patents in Facilitating Innovaiton
    Doi: 10.2139/ssrn.2503314
  • Reports

    2014

  • Liddicoat, JE., 2014. Exposure draft intellectual property laws amendment bill 2014, IP Australia
  • Liddicoat, JE., 2014. IP Australia Patentable Subject Matter Consultation Paper on an Objects Clause and Exclusion from Patentability